Tamar Ben-Yedidia
Chief Tech/Sci/R&D Officer bij SCINAI IMMUNOTHERAPEUTICS LTD.
Profiel
Tamar Ben-Yedidia is currently the Chief Science Officer at Scinai Immunotherapeutics Ltd.
since 2004.
Prior to this, she worked as a Lab Manager at Biotechnology General (Israel) Ltd.
from 1991 to 1994.
Dr. Ben-Yedidia received her undergraduate degree from Tel-Aviv University and her doctorate degree from Weizmann Institute of Science in 2000.
Actieve functies van Tamar Ben-Yedidia
Bedrijven | Functie | Begin |
---|---|---|
SCINAI IMMUNOTHERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 01-01-2004 |
Eerdere bekende functies van Tamar Ben-Yedidia
Bedrijven | Functie | Einde |
---|---|---|
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Corporate Officer/Principal | 01-01-1994 |
Opleiding van Tamar Ben-Yedidia
Tel-Aviv University | Undergraduate Degree |
Weizmann Institute of Science | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |